Osaic Holdings’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Osaic Holdings's XGN Position: Q2 2026 in Review
Osaic Holdings increased its Exagen (XGN) stake by 10% in Q2 2026, buying an estimated $377 and bringing the position to 1,100 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #6930.
Osaic Holdings first reported a position in XGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $66K in Q2 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Osaic Holdings held 1,100 shares of Exagen worth $5.12K as of Q2 2026.
- Osaic Holdings bought 100 Exagen shares in Q2 2026, an estimated $377.
- Exagen made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6930 holding.
- Osaic Holdings first reported a position in Exagen in Q1 2021 and has held it in 19 quarters since.
- Osaic Holdings's Exagen position peaked at $66K in Q2 2021.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.